605 related articles for article (PubMed ID: 25066692)
1. Roles for chemokines in liver disease.
Marra F; Tacke F
Gastroenterology; 2014 Sep; 147(3):577-594.e1. PubMed ID: 25066692
[TBL] [Abstract][Full Text] [Related]
2. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
3. Chemokines as immune mediators of liver diseases related to the metabolic syndrome.
Berres ML; Nellen A; Wasmuth HE
Dig Dis; 2010; 28(1):192-6. PubMed ID: 20460910
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in liver inflammation and fibrosis.
Wasmuth HE; Tacke F; Trautwein C
Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
[TBL] [Abstract][Full Text] [Related]
5. Role of chemokine pathways in hepatobiliary cancer.
Ehling J; Tacke F
Cancer Lett; 2016 Sep; 379(2):173-83. PubMed ID: 26123664
[TBL] [Abstract][Full Text] [Related]
6. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
7. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics.
Wald O; Weiss ID; Galun E; Peled A
Cytokine; 2007 Jul; 39(1):50-62. PubMed ID: 17629707
[TBL] [Abstract][Full Text] [Related]
8. Innate immune response and hepatic inflammation.
Szabo G; Mandrekar P; Dolganiuc A
Semin Liver Dis; 2007 Nov; 27(4):339-50. PubMed ID: 17979071
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J; Choi SS; Diehl AM
Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
[TBL] [Abstract][Full Text] [Related]
10. Chemokine-directed immune cell infiltration in acute and chronic liver disease.
Karlmark KR; Wasmuth HE; Trautwein C; Tacke F
Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):233-42. PubMed ID: 19072358
[TBL] [Abstract][Full Text] [Related]
11. Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.
Okabe H; Hayashi H; Nakagawa S; Imai K; Nitta H; Arima K; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
Histol Histopathol; 2016 Feb; 31(2):141-8. PubMed ID: 26398776
[TBL] [Abstract][Full Text] [Related]
12. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.
Shields PL; Morland CM; Salmon M; Qin S; Hubscher SG; Adams DH
J Immunol; 1999 Dec; 163(11):6236-43. PubMed ID: 10570316
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acids and hepatic stellate cells in liver disease.
Lee YS; Jeong WI
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():75-9. PubMed ID: 22320921
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines].
Wasmuth HE; Weiskirchen R
Z Gastroenterol; 2010 Jan; 48(1):38-45. PubMed ID: 20072995
[TBL] [Abstract][Full Text] [Related]
15. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis.
Zhao J; Zhou G; Li M; Li W; Lü J; Xiong L; Liang L; Zhao Y; Xu D; Yu J
Scand J Gastroenterol; 2010 Nov; 45(11):1360-71. PubMed ID: 20560816
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
17. Chemokines and Chemokine Receptors in the Development of NAFLD.
Roh YS; Seki E
Adv Exp Med Biol; 2018; 1061():45-53. PubMed ID: 29956205
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptors in acute liver injury and regeneration.
Chen Y; Sun R
Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
Soria G; Ben-Baruch A
Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
[TBL] [Abstract][Full Text] [Related]
20. Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis.
Zimmermann HW; Tacke F
Inflamm Allergy Drug Targets; 2011 Dec; 10(6):509-36. PubMed ID: 22150762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
